Back to Search Start Over

Real-world outcomes of long-term use of silexan in patients with anxiety disorders: a single-centre experience.

Authors :
Marchevsky, Sergio
Source :
International Journal of Psychiatry in Clinical Practice. Aug2024, p1-4. 4p. 1 Illustration.
Publication Year :
2024

Abstract

AbstractObjectiveMethodsResultsConclusions\nKey PointsTo evaluate the effectiveness and safety of long-term use of silexan in patients with a wide range of anxiety disorders.A retrospective chart review was conducted on 50 patients diagnosed with various anxiety disorders who were prescribed silexan. The primary outcomes measured included the resolution of anxiety symptoms, changes in Generalized Anxiety Disorder-7 (GAD-7) scores, and Clinical Global Impressions-Improvement (CGI-I) scores. The duration of silexan use and any reported adverse events were also recorded.Silexan effectively resolved anxiety symptoms in 35 patients, with 24 out of 25 patients who received silexan for more than 12 weeks showing significant improvement. Median GAD-7 and CGI-I scores decreased significantly (p<0.001). By the end of the follow-up period, 46% of patients had minimal anxiety and 24% had mild anxiety. No adverse events were reported during the study period.Long-term use of silexan is feasible, safe, and effective in managing a wide range of anxiety disorders in real-world clinical settings.While silexan has shown promising results in the treatment of anxiety disorders in various clinical trials, there is a significant gap in our understanding of its effects in long-term use.The present study supports the long-term use of silexan as a safe and effective alternative or adjunct to conventional anxiolytics.Using silexan as an alternative or adjunct to traditional anxiolytics may provide additional treatment options, potentially reducing the burden of these prevalent and disabling conditions.Silexan may be an appropriate choice for patients seeking natural or complementary treatments for anxiety.While silexan has shown promising results in the treatment of anxiety disorders in various clinical trials, there is a significant gap in our understanding of its effects in long-term use.The present study supports the long-term use of silexan as a safe and effective alternative or adjunct to conventional anxiolytics.Using silexan as an alternative or adjunct to traditional anxiolytics may provide additional treatment options, potentially reducing the burden of these prevalent and disabling conditions.Silexan may be an appropriate choice for patients seeking natural or complementary treatments for anxiety. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13651501
Database :
Academic Search Index
Journal :
International Journal of Psychiatry in Clinical Practice
Publication Type :
Academic Journal
Accession number :
179056973
Full Text :
https://doi.org/10.1080/13651501.2024.2391301